(NASDAQ: CDNA) Caredx's forecast annual revenue growth rate of 10.85% is forecast to beat the US Diagnostics & Research industry's average forecast revenue growth rate of 5.13%, and it is also forecast to beat the US market's average forecast revenue growth rate of 10.56%.
Caredx's revenue in 2025 is $346,421,000.On average, 3 Wall Street analysts forecast CDNA's revenue for 2025 to be $20,685,490,995, with the lowest CDNA revenue forecast at $20,579,530,910, and the highest CDNA revenue forecast at $20,818,400,466. On average, 3 Wall Street analysts forecast CDNA's revenue for 2026 to be $23,717,853,694, with the lowest CDNA revenue forecast at $23,575,144,447, and the highest CDNA revenue forecast at $23,820,138,862.
In 2027, CDNA is forecast to generate $26,678,221,442 in revenue, with the lowest revenue forecast at $26,678,221,442 and the highest revenue forecast at $26,678,221,442.